TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
SwePharm AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
361
|
2,588
|
7,010 |
Financial expenses |
0
|
41
|
39 |
Earnings before taxes |
-427
|
-975
|
2,059 |
EBITDA |
-307
|
-704
|
2,367 |
Total assets |
1,389
|
5,053
|
7,927 |
Current assets |
570
|
3,940
|
5,659 |
Current liabilities |
76
|
1,213
|
1,311 |
Equity capital |
1,154
|
3,580
|
4,332 |
- share capital |
105
![]() |
105
![]() |
105 |
Employees (average) |
1
|
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
83.1%
|
70.8%
|
54.6% |
Turnover per employee |
361
|
1,294
|
3,505 |
Profit as a percentage of turnover |
-118.3%
|
-37.7%
|
29.4% |
Return on assets (ROA) |
-30.7%
|
-18.5%
|
26.5% |
Current ratio |
750.0%
|
324.8%
|
431.7% |
Return on equity (ROE) |
-37.0%
|
-27.2%
|
47.5% |
Change turnover |
-2,227
|
-4,422
|
3,478 |
Change turnover % |
-86%
|
-63%
|
98% |
Chg. No. of employees |
-1
|
0
![]() |
0 |
Chg. No. of employees % |
-50%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.